RIOZONE-S

Riozone-S is a potent combination of Ceftriaxone Sodium, a third-generation cephalosporin antibiotic, and Sulbactam, a beta-lactamase inhibitor, designed to enhance the effectiveness of the antibiotic against resistant bacterial infections.
Manufactured ensuring compliance with WHO-GMP standards for safety and efficacy.
This formulation is available in vial form for intravenous or intramuscular injection, commonly used in hospitals for the treatment of severe bacterial infections.

Riozone-S is used to treat a wide range of bacterial infections, including:
- Respiratory tract infections (e.g., pneumonia, bronchitis)
- Urinary tract infections (UTIs)
- Skin and soft tissue infections
- Intra-abdominal infections
- Bone and joint infections
- Meningitis and septicemia
- Post-surgical infections
It is especially useful for treating infections caused by beta-lactamase-producing bacteria, due to the presence of Sulbactam, which enhances Ceftriaxone’s activity.

Broad-Spectrum Antibiotic Action: Ceftriaxone Sodium is effective against a wide range of bacteria, including gram-negative and gram-positive organisms.
Enhanced Efficacy: Sulbactam inhibits beta-lactamase enzymes produced by bacteria, which would otherwise degrade Ceftriaxone, ensuring the antibiotic remains effective.
Rapid Action: Works quickly to eliminate bacteria and alleviate symptoms of severe infections.
Reduces Treatment Failure: The combination of Ceftriaxone and Sulbactam prevents bacterial resistance, making it highly effective in treating complicated infections.

Dosage:
- Riozone-S is administered via intravenous or intramuscular injection. The dosage is typically determined by the severity of the infection and the patient's condition.
- A healthcare provider will determine the exact dosage and frequency, generally administered once or twice daily, depending on the infection.
Administration:
- The injection should be given under medical supervision.
- Reconstitute the vial with the recommended diluent and administer the injection according to the healthcare provider's instructions.

Ceftriaxone Sodium works by inhibiting bacterial cell wall synthesis, leading to the destruction of the bacteria.
Sulbactam works by inhibiting beta-lactamase enzymes that certain bacteria produce to resist antibiotics. This prevents Ceftriaxone from being broken down, enhancing its antibacterial activity.
The combination of these two agents provides powerful protection against resistant bacterial strains, allowing for effective treatment of severe infections.